A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market; to the Committee on the Judiciary.

S. 27 — A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market; to the Committee on the Judiciary.

By Mr. KOHL (for himself, Mr. Grassley, Mr. Durbin, Ms. Collins, Ms. Klobuchar, Mr. Franken, Mr. Brown of Ohio, and Mr. Sanders), S122 [25JA]

Text, S144 [25JA]

Cosponsors added, S412 [1FE]

Reported (no written report), S4845 [22JY]